Arbutina David MD is categorized under Internal Medicine Doctors in State College, PA and active since 2010.
Arbutina David MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact David Arbutina at the company’s single location by writing to 200 Scenery Drive, State College, Pennsylvania PA 16801 or by phoning (814) 231-4560. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Arbutina David MD |
| Contact Person: | David Arbutina |
| Address: | 200 Scenery Drive, State College, Pennsylvania 16801 |
| Phone Number: | (814) 231-4560 |
| Website Address: | geisinger.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Arbutina David MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David Arbutina for inquiries that concern Arbutina David MD by calling the company number (814) 231-4560, as your correspondence is most welcome. Additionally, the physical location of the single location of Arbutina David MD can be found at the coordinates 40.78534,-77.81971 as well as the street address 200 Scenery Drive in State College, Pennsylvania 16801.
For its online presence, you may visit Arbutina David MD’s website at geisinger.org and engage with its social media outlets through on Twitter and on Facebook.